ReviewFundamental research2026
Biological sequence analysis: Advances, medical applications, and challenges.
Review in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI for biology: Catalyzing interdisciplinary innovation to unravel life's complexity and address biomedical challenges.Fundamental research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With continuous developments in biotechnology and information technology, we are entering the era of biological sequence big data. Extracting valuable insights from large-scale data to decipher life activities presents a major challenge. Artificial intelligence, particularly big data analysis and natural language processing technologies, has emerged as a crucial tool in biological sequence analysis. These technologies facilitate pattern detection, offering new perspectives on complex biological processes. Notably, AlphaFold and ESM models have achieved significant strides in protein structure prediction and functional annotation. These breakthroughs not only accelerate fundamental biological research but also provide innovative tools and strategies for disease diagnosis and drug discovery. In this perspective, we discuss the advancements in biological sequence analysis and focus on their extensive medical applications. Additionally, we highlight relevant challenges and propose further directions, emphasizing the need for ongoing innovation in sequence analysis to fully realize its potential in biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.